 NEW YORK, Oct. 15, 2021 GLOBE NEWSWIRE -- The board of directors of Royalty Pharma plc Nasdaq: RPRX has approved the payment of a dividend for the fourth quarter of 2021 of 0.17 per Class A ordinary share. 